{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "medicine:surgery:vascular:dvt:006:anticoagulation",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-09T01:37:54.000Z",
    "modified": "2026-01-09T01:37:54.000Z",
    "contributors": [
      "copilot-agent"
    ],
    "status": "validated",
    "confidence": 0.85
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/dvt",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "core"
  },
  "content": {
    "title": "DVT Anticoagulation",
    "definition": "Anticoagulation for 3 months (provoked), indefinitely (unprovoked or recurrent). DOACs preferred over warfarin."
  },
  "learning_objectives": [
    "Understand DVT Anticoagulation"
  ],
  "clinical_pearls": [
    "Key point about DVT Anticoagulation"
  ],
  "evidence": {
    "level": "moderate",
    "sources": [
      "Expert consensus"
    ]
  },
  "prerequisites": [],
  "relationships": {
    "related_concepts": [],
    "parent_concepts": [],
    "child_concepts": []
  }
}